Today, Glooko announced the launch of their integration with the Novo Nordisk connected insulin pen on our diasend® platform and the release of their Annual Diabetes Report. With diasend, doctors were able to see and advise patients based on recorded insulin dose data from connected Novo Nordisk pens without having to invest additional time. Now, to raise the bar for patient convenience even further, Glooko is launching the ability to also upload pen data remotely – straight from any near field
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
Glooko Unveils Web-based Diabetes Analytics Platform
Diabetes management provider Glooko has unveiled new version of the Glooko Web Application (Population Tracker) that includes streamlined navigation and a large array of diabetes analytics, charts and graphs. The new web application version, which will now be rolled out in the U.S. and Canada and continue with the first European phase later this year, includes support for IDC’s Ambulatory Glucose Profile (AGP), an important standard with clinicians.The new web application version, which will now
Read More
Novo Nordisk & Glooko Launch Integrated Diabetes Management App
Novo Nordisk and Glooko has announced the launch of their new integrated diabetes management app, Cornerstones4Care (C4C app) for patients. The C4C mobile app integrates Novo Nordisk's extensive knowledge of diabetes and personalized patient support with Glooko's digital platform and data analytics expertise. Cornerstones4Care Powered by Glooko AppThe integrated app concept will initially enable people with diabetes to easily measure and track their blood glucose, activity and meals all in one
Read More
Glooko Raises $35M to Expand Diabetes Data Platform Internationally
Glooko, a Mountain View, CA-based provider of diabetes data management has rasied $35 million in Series C funding led by Georgian Partners with participation from Insulet Corporation, Mayo Clinic, Canaan Partners, Social Capital, Medtronic and Samsung NEXT. The company plans to use the funding to expand its’ commercialization efforts in France, Germany, the U.K., Asia and the Middle East, and further development efforts in data analytics and artificial intelligence to provide personalized
Read More
Study: Glooko’s Diabetes Mobile App Improved Glucose & A1C Rates
Diabetes data management company Glooko announced that its mobile app was associated with a drop in average blood glucose, estimated A1C (eA1C) and hyperglycemia rates in people with diabetes, according to results of two retrospective studies. Furthermore, usage of the Glooko mobile app was also associated with an increase in blood glucose test rate. Increased blood glucose testing rates have been shown to directly correlate with improvements in glycemic control, as evidenced by this
Read More
Ascensia Diabetes Care, Glooko Partner to Integrate Diabetes Data for Consumers
Ascensia Diabetes Care and Glooko, a remote patient monitoring platform for diabetes has announced an integration partnership to improve diabetes data management and analytics. The integration includes Glooko's Diabetes Data Management Platform and Ascensia's blood glucose monitoring systems that will allow people with diabetes and health care professionals to access and analyze highly accurate blood glucose data through the digital platform of their choice. The collaboration includes all
Read More
Novo Nordisk, Glooko Team Up to Develop Digital Diabetes Solutions
Pharmaceutical company Novo Nordisk and Glooko, a remote patient monitoring platform for diabetes are teaming up to develop digital health solutions for diabetes. As part of the non-exclusive collaboration, both companies will work together to create co-branded digital health solutions that will deliver personalized, digital services to support people with diabetes in areas including treatment adherence and blood glucose management.For Novo Nordisk, the integration of these offerings within its
Read More
Glooko, Diasend Merge to Create International Diabetes Management Platform
Diabetes management platform companies Diasend and Glooko announced that it will merge into one company under the Glooko name to deliver the world’s premier diabetes management platform focused on making diabetes management easier for people with diabetes and the teams who care for them. In addition to its merger, the companies have raised $8M in equity financing, led by global venture capital firm Canaan Partners, to accelerate integration and sales efforts. Other investors include Social
Read More
AMC Health, Glooko Partner to Deliver BYOD Solution To Patients With Diabetes
AMC Health, a provider of proven remote patient monitoring and engagement solutions and Glooko Inc., a population health platform for diabetes management has announced a partnership to help clinicians and patients improve diabetes outcomes at lower costs.Glooko is one of many FDA 510(k) cleared devices now integrated into AMC Health’s expanding FDA-cleared CareConsole® virtual care platform. Glooko is currently being used in 1,000+ health systems, health plans and employers in the USA, including
Read More